Approximately 23,000 scientists, students, researchers, advocates and community members gathered to advance cancer science at annual conference in San Diego
Seven researchers from the University of Hawaiʻi Cancer Center were selected to present groundbreaking science through panels and/or poster presentations at the prestigious American Association for Cancer Research (AACR) Annual Meeting in April in San Diego.
The presenters were Drs. Bharat Singh, Flavia Novelli, Lenora Loo, Jangsoon (Jason) Lee, Youping Deng and Hikaru Murakami; and Michelle Nagata, MS, PhD candidate, Cell and Molecular Biology, and graduate assistant. UH Cancer Center Director Dr. Naoto T. Ueno also participated as his research was widely featured in multiple presentations. Over 23,000 people attended the conference April 17-22 to focus on advancing cancer science to save lives globally.
AACR is the first and largest cancer research organization dedicated to accelerating the conquest of cancer. This year, the AACR Annual Meeting was held in San Diego, CA from April 17-22, 2026. The focus was on precision, partnership, and purpose, with “Advancing Cancer Science to Save Lives Globally” as the theme.
Seven UH Cancer Center faculty, students, postdocs, and research team members were selected to present their work through poster presentations at the Annual Meeting. Furthermore, The UH Cancer Center’s Multiethnic Cohort Study (MEC) data was well represented at the Annual Meeting as researchers from across the nation, including California and New Jersey, utilized MEC data within their highlighted projects at AACR. The UH Cancer Center’s research was highlighted throughout the six days of the Annual Meeting, demonstrating the rigorous and cutting edge research conducted in Hawaiʻi:
Additional UH Cancer Center attendees and presenters included:
UH Cancer Center’s engagement in AACR and other cancer and scientific field-related conferences provides avenues to highlight the groundbreaking research conducted here to national and international audiences, while also providing spaces for co-learning and future collaborations.
AACR’s mission is to prevent and cure cancer through various priorities including research, education, communication, collaboration, science policy/advocacy, and funding for cancer research. According to AACR estimates, more than 23,000 attended the Annual Meeting this year from 74 countries and territories, with nearly 250 clinical trials presented at the meeting. Additionally, the meeting has been mentioned by more than 4,500 authors, thus generating 176.5 million impressions online and counting. Attendance and participation in the AACR Annual Meeting provides the UH Cancer Center a large national and international audience to discuss the groundbreaking research conducted at center in Honolulu — the only National Cancer Institute-designated cancer center in the Pacific region — as well as provide opportunities for future collaborations.

Dr. Flavia Novelli, Director, Senior Scientist, Department of Cancer Biology, University of Hawaiʻi Cancer Center.

From left: Drs. Naoto Ueno, UH Cancer Center Director; and Jangsoon (Jason) Lee, Associate Professor, Director of Preclinical Core, University of Hawaiʻi Cancer Center.

Dr. Bharat Singh, postdoctoral fellow, Cancer Biology Program, University of Hawaiʻi Cancer Center.

Dr. Bharat Singh, right, Director, postdoctoral fellow, Cancer Biology Program, University of Hawaiʻi Cancer Center, discusses his poster with a fellow AACR attendee.

From left: Michelle Nagata, MS, PhD candidate, Cell and Molecular Biology, and graduate assistant; and Dr. Lenora Loo, Professor, Cancer Biology Program, University of Hawaiʻi Cancer Center.

Michelle Nagata, MS, PhD Candidate Cell and Molecular Biology, Graduate Assistant, University of Hawaiʻi Cancer Center

Michelle Nagata, MS, PhD Candidate Cell and Molecular Biology, Graduate Assistant, University ofHawaiʻi Cancer Center discussing her project and poster with fellow AACR attendees.
Learn more about the UH Cancer Center’s Multiethnic Cohort Study.
Learn more about the American Association for Cancer Research.
###
About the University of Hawaiʻi Cancer Center
The University of Hawaiʻi Cancer Center is dedicated to saving lives in Hawaiʻi and the Pacific, and inspiring hope by working to conquer cancer. The flagship priority is to understand and address cancer health disparities. The center strives to achieve this through research, education, patient care, and community outreach, focusing on the unique and diverse ethnic, cultural, and environmental characteristics of Hawaiʻi and the Pacific.
The UH Cancer Center is one of only 74 institutions designated by the National Cancer Institute (NCI), representing a significant mark of excellence, and is the only NCI-designated cancer center in Hawaiʻi and the Pacific. The center contributes more than $57 million to Hawaiʻi's economy through scientific research, clinical trials, and other activities.
As part of the University of Hawaiʻi at Mānoa, the UH Cancer Center operates out of facilities located in Kakaʻako. The center directly employs more than 300 faculty and staff, with an additional 200 affiliate members and cooperative agreements with organizations that are part of the Hawaiʻi Cancer Consortium. The consortium includes The Queen’s Health Systems, Hawaiʻi Pacific Health, Kuakini Medical Center, Adventist Health Castle, Hawaiʻi Medical Service Association (HMSA), and the John A. Burns School of Medicine (JABSOM), all working together with the UH Cancer Center to advance cancer research and treatment in the state.
Learn more at https://www.uhcancercenter.org | Connect with us on Facebook | Instagram | X | LinkedIn